Drug makers in Nigeria have, once again, called for 100 percent removal of tariff on their excipients, including raw and packaging materials.
The on-going Common External Tariff (CET) imposes between five and 20 percent duty on inputs used by Nigeria’s pharmaceutical companies while allowing zero
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
ODINAKA ANUDU
Nigeria's leading finance and market intelligence news report. Also home to expert opinion and commentary on politics, sports, lifestyle, and more